C-reactive protein levels in community-acquired pneumonia

Abstract
The diagnostic value of C-reactive protein (CRP) admission serum levels as an indicator of the aetiology of community-acquired pneumonia (CAP) was evaluated.A cohort of 1,222 patients with CAP was assessed. CRP levels were analysed in 258 patients with a single aetiological diagnosis.The mean CRP values in patients with pyogenic, atypical, viral andLegionella pneumophilapneumonia were: 16 mg·dL−1, 13 mg·dL−1, 14 mg·dL−1and 25 mg·dL−1, respectively. CRP levels were not significantly different among patients outcome research team (PORT) groups (19 mg·dL−1in groups I–II, 16 mg·dL−1in group III and 16 mg·dL−1in groups IV–V. A cut-off point of 25 mg·dL−1had a sensibility, specificity, positive predictive value and negative predictive value of 0.6, 0.83, 0.3, and 0.94, respectively. After controlling for age and PORT score, the odds of having a CRP level >25 mg·dL−1was 6.9 times higher in patients withL. pneumophilapneumonia than in those with non-L. pneumophilapneumonia.Patients withLegionella pneumophilapneumonia had higher C-reactive protein levels than those with pneumonia of any other aetiology, independently of severity of infection. Being a cheap and readily available test, C-reactive protein may be a useful adjunctive procedure in the diagnosis of community-acquired pneumonia.